Navigation Links
Definiens to Introduce New Generation of Products for Tissue-based Biomarker Research at the International Definiens Symposium
Date:9/20/2011

in tissue biopsies is used for research or diagnosis and the interpretation is subjective," says Thomas Heydler, CEO of Definiens.  "With the statistical power of many detailed readouts from a tumor specimen combined with our new data mining capabilities, we are addressing the needs of scientists and exploring new possibilities in tissue-based biomarker development."

In recent years, Definiens has generated a large footprint over the entire bandwidth of biomedical applications, specifically in the field of Quantitative Digital Pathology and Biomarker Research, which continues to expand with the upcoming additions to the company's suite of products. For more information about the upcoming product launch, please visit quantitative-digital-pathology.definiens.com.

For more information on the upcoming International Definiens Symposium, please visit www.definiens.com/community/symposium.html.

About Definiens

Definiens is a leading Health Image Intelligence™ company that develops software solutions for biomedical image analysis, data mining and clinical decision support. The company's software analyzes images from cell-based assays, whole tissue slides and full body scans and allows users to correlate this information with data derived from other sources, supporting better decisions in research, diagnostics and therapy. By automating analysis workflows and generating new knowledge, Definiens provides pharmaceutical and biotechnology companies, research institutions, clinical service organizations and medical professionals with deeper insights, faster results and better decision support. Harnessing the power of image intelligence, Definiens supports personalized medicine and aims to significantly improve the quality of patients' lives.

Definiens is headquartered in Munich, Germany, and
'/>"/>

SOURCE Definiens
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
2. Advanced Cell Diagnostics and Definiens Partner to Develop Tool for Quantitative Biomarker Analysis
3. Mindray Introduces DP-50 Portable Ultrasound System in the U.S.
4. Bausch + Lomb and Technolas™ Perfect Vision Introduce VICTUS™ Femtosecond Laser Platform at 2011 ESCRS Meeting
5. Lewis County Introduces Prescription Discount Card to Help Alleviate High Costs
6. NeurOptics Introduces First Hand-held Variable Light Condition Pupillometer to Optimize Outcomes for Refractive Surgery and Premium Intraocular Lens Candidates
7. Bourns Introduces Two New Industrial-Grade Panel Control Models
8. Verathon® Introduces the Heartscape™ 3D ECG System with 80-Lead Vest in Europe; Technology Provides More Complete Data to Help Diagnose Acute Myocardial Infarction (MI)
9. Otero County Introduces Prescription Discount Card to Help Alleviate High Costs
10. UBM Canon Introduces a Compelling New Virtual Conference Focused on Track & Trace Solutions for the Pharma Sector
11. YASOO Health Introduces IronUp™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013  Decision Resources, one of the ... pharmaceutical and healthcare issues, finds that the ... efficacy endpoints, including overall survival and time ... over surveyed U.S. and European oncologists, prescribing ... breast cancer. The two novel emerging therapies ...
(Date:5/21/2013)... MOUNTAIN VIEW, Calif. , May 21, 2013 ... the design and manufacture of wireless personal healthcare ... to broaden its reach, announcing the release of ... of wireless blood pressure monitors and scales: the ... Tracker. (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) ...
(Date:5/21/2013)... , May 21, 2013 BioElectronics Corp. ... consumer electronic devices, announced that CEO, ... to the FDA,s Medical Advisory Committee, Orthopedic and ... products for over the counter sales. ... its medical device classification schema," Whelan said.  "While ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... more ... study, DURANGO, Colo. and NEW HAVEN, Conn., ... innovation networks, today announced,that the company is providing ... Applied Spine,s Stabilimax NZ(R) Dynamic Spine,Stabilization System. Stabilimax ...
... 18 Worldwide markets of,approved EGFr/HEr2 inhibitors grew by ... more than $3.2 billion, exceeding total sales reported in,2005. ... for these drugs and fueling continued rapid market growth. ... 50 novel,agents targeting this pathway are in development. ...
Cached Medicine Technology:Syndicom SpineConnect Web Platform Chosen for Applied Spine's Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System 2Syndicom SpineConnect Web Platform Chosen for Applied Spine's Leg and Back Pain Clinical Trial of Its Stabilimax NZ(R) Dynamic Spine Stabilization System 3
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to improve ... the Creative Corridor region, is releasing results for its ... on Thursday, May 23rd at 10:30 a.m. The ... , The survey is a critical component to ... attract, nurture and retain people of diverse backgrounds, cultures ...
(Date:5/21/2013)... Modern couples have countless strains on ... Sexuality and Relationship Workshops, couples are learning the ... habits for their relationship. There are both private ... individuals at Texas Counseling. Their goal is to ... to develop long term solutions. , Developing ...
(Date:5/21/2013)... genetic features of pulmonary fibrosis by physicians and scientists ... lead to improved treatment of this deadly lung disease, ... . , The study found that a particular genetic ... fibrosis, a chronic progressive disease with a median survival ... researchers may want to consider including genetic testing in ...
(Date:5/21/2013)... of the adenoids and tonsils, is performed 500,000 times ... treatment for children with obstructive sleep apnea. However, ... executive functioning, behavior, sleep apnea symptoms, and quality of ... A study led by Susan Redline, MD, MPH, ... and Associate Clinic Director of the Division of Sleep ...
(Date:5/21/2013)... May 21, 2013 Today, Zane Benefits, ... and FSA accounts. Zane Benefits, which provides comprehensive ... is the leader in defined contribution and ... . , According to Zane Benefits’ website, the Affordable ... signed into law in 2010 and impacts many areas ...
Breaking Medicine News(10 mins):Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3
... LOS ANGELES, Sept. 5 In a letter sent ... on Governor,Schwarzenegger and Assembly Speaker Nunez to answer seven ... care reform, that has,not been publicly released even though ... session. The full letter available below. FTCR wrote: ...
... estrogen receptor in mammary gland development may help scientists ... to new research from the University of Cincinnati (UC). ... the National Institutes of Health (NIH) developed a standard ... the estrogen receptors role in human diseases. , Unfortunately, ...
... Sept. 5 NBTY, Inc. (NYSE: NTY ), (http://www.NBTY.com ), a leading global manufacturer and marketer of nutritional,supplements, today ... rounded):, ... ... FOR THE MONTH OF AUGUST ...
... atrial fibrillation , , WEDNESDAY, Sept. 5 (HealthDay News) -- Cardiac ... heartbeat called atrial fibrillation. , The drug, dronedarone, is not ... has proven effective in two major trials, with fewer side ... Sept. 6 issue of the New England Journal of ...
... The National Association for Sport,and Physical Education (NASPE) ... help to educate, challenge, and encourage all children ... healthy and fit life. As,the new sponsor of ... assist the nonprofit education association in promoting this,comprehensive ...
... for More Nurse Educators, WASHINGTON, Sept. 5 ... is pleased to announce that the Johnson &,Johnson ... new national,scholarship program designed to increase the number ... Minority Nurse Faculty Scholars,program will provide financial assistance ...
Cached Medicine News:Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 2Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 3Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 4Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 5Health News:The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise 6Health News:New 'knock-out' gene model provides molecular clues to breast cancer 2Health News:New 'knock-out' gene model provides molecular clues to breast cancer 3Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 2Health News:NBTY Announces Preliminary Unaudited Net Sales Results For August 2007 3Health News:Drug, Pacemaker Fight Irregular Heartbeat 2Health News:Drug, Pacemaker Fight Irregular Heartbeat 3Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 2Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 3Health News:Johnson & Johnson Campaign for Nursing's Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program 2Health News:Johnson & Johnson Campaign for Nursing's Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program 3Health News:Johnson & Johnson Campaign for Nursing's Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: